Skip to main content

News

Sub-prime hits energy

The fallout from the US sub-prime mortgage meltdown is complicating seasonal uncertainties for energy markets. David Watkins reports

Big business responds to Australia’s carbon proposals

A report launched today by the Australian Business and Climate Group (ABCG) has highlighted that plans for an Australian emissions trading scheme (ETS) will not, on their own, be a sufficient response to meet future emissions targets.

Nymex confirms sale talks

Following months of heightened speculation, Nymex Holdings, the parent company of the New York Mercantile Exchange (Nymex) has released a statement confirming it has been in “preliminary” talks to be purchased.

Van Eck goes nuclear at Amex

New York-based asset manager Van Eck Global has launched its Market Vectors Nuclear Energy ETF (exchange-traded fund) on the American Stock Exchange (Amex). It is the first ETF listed in the US that enables investors to gain exposure to companies…

AES wind power blows into China

Global power company AES has announced plans to expand its wind generation business into China through the creation of a joint venture with renewable energy producer Guohua Energy Investment.

Calyon Financial and Fimat to merge

Investment banks Société Générale and Calyon have agreed to merge the brokerage activities currently carried out by their respective subsidiaries, Fimat and Calyon Financial.

Evolution expands into global merchant banking

Evolution Markets Financial Services, a subsidiary of environmental market brokerage Evolution Markets, is set to expand its range of activities across global merchant banking within the environmental, energy and clean energy sectors.

Barcap increases commodities appetite

Investment bank Barclays Capital has sharply increased its appetite for risk-taking in the first half of 2007, with all the new risk being taken in the commodities segment, according to Barcap reports.

You need to sign in to use this feature. If you don’t have a FX Markets account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an indvidual account here: